Status:
RECRUITING
Liver Ischemia-reperfusion Injury and Clinical Data Analysis
Lead Sponsor:
Qin Zhang
Conditions:
Liver Injury
Eligibility:
All Genders
18-70 years
Brief Summary
Searching for new targets for the diagnosis and treatment of liver ischemia-reperfusion injury.
Detailed Description
Through the analysis of serological data during liver resection elective surgery with hepatic pedicle occlusion and reperfusion, as well as the analysis of patient-related data, we aim to identify key...
Eligibility Criteria
Inclusion
- Willingness to participate in the study and has signed an informed consent form. 2) Age ≥ 18 years and ≤ 70 years. 3) ASA classification ≤ III. 4) Criteria for liver ischemia-reperfusion injury patients: patients undergoing elective liver resection surgery with hepatic pedicle occlusion and reperfusion during the procedure.
Exclusion
- 1\) Patients with adverse events during surgery. 2) Patients in the end stage of disease with liver failure. 3) Liver tumor metastasis with concomitant severe heart failure or chronic renal insufficiency, etc. 4) Deemed unsuitable for participation in the study based on the judgment of the researchers.
- \-
Key Trial Info
Start Date :
October 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT06080308
Start Date
October 10 2023
End Date
September 30 2024
Last Update
April 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030